Atlas FDA

MAMMAPRINT

FDA 510(k) clearance K070675 · decided 2007-06-22

Clearance details

K-number
K070675
Device name
MAMMAPRINT
Applicant
Agendia BV
Decision
Substantially Equivalent
Date received
2007-03-12
Decision date
2007-06-22
Days to decision
102 days
Clearance type
Traditional
Product code
NYI
Device class
2
Regulation number
866.6040
Medical specialty
Immunology
Advisory committee
Immunology
Location
Amsterdam, NL
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Agendia BV

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
MammaPrint FFPE NGS Kit (K210973)Agendia, Inc.2022-09-08
MammaPrint (K201902)Agendia, Inc.2020-11-05
MAMMAPRINT FFPE (K141142)Agendia2015-01-23
PROSIGNA BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY (K141771)Nanostring Technologies, Inc.2014-11-07
PROSIGNA(TM) BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY (K130010)Nanostring Technologies2013-09-06
MAMMAPRINT (K101454)Agendia2011-01-28
MODIFICATION TO MAMMAPRINT (K081092)Agendia2009-12-11
MODIFICATION TO MAMMAPRINT (K080252)Agendia BV2008-07-21
MAMMAPRINT (DEN070009)Agendia BV2007-02-06

Recalls involving this device

RecordFirmDate
Agendia MammaPrint, Catalog Numbers MP01, MP US version 03 recall (Z-1321-2010)Agendia Inc2010-04-12